Similar anti-tumor and immunomodulatory effects were also reported in mice bearing hepatoma or sarcoma tumors with the administration of recombinant HP-NAP fused with maltose binding protein (rMBP-NAP) [74]. The gene discussed is HP; the disease is neoplasm.